Smaller Vesicles Surprisingly Suppress Cell-Penetrating Peptide Entry Due to Reduced Membrane Fluidity | Research

The takeaway

Smaller vesicles suppressed CPP-mediated membrane penetration — the opposite of what curvature theory predicted — because restricted lipid mobility in smaller vesicles prevents the membrane restructuring needed for peptide entry.

Fluidity trumps curvature
Lipid mobility, not membrane curvature, is the key factor determining whether CPPs can cross membranes

What the researchers found

Smaller vesicles suppressed CPP cytolysis despite higher membrane curvature, because reduced lipid mobility in smaller vesicles restricts the local phase transitions required for CPP membrane penetration.

Why it matters

Understanding what controls CPP membrane crossing is essential for designing effective drug delivery systems. This study reveals lipid mobility as a key parameter, changing how we think about optimizing CPP-based carriers.

The numbers in context

Smaller vesicles suppressed CPP entry; lipid mobility is the key factor; osmotic pressure helps only with sufficient mobility

How the study worked

In vitro model vesicle (liposome) studies varying vesicle diameter to control membrane curvature. Measured CPP cytolysis (membrane penetration) across different vesicle sizes. Analyzed relationship between lipid mobility, curvature, and CPP penetration.

Who was studied

Phospholipid vesicles of varying sizes

What this study cannot tell us

Model vesicle study — artificial membranes lack the protein and carbohydrate complexity of real cell membranes. Findings need validation in cell-based systems. Limited CPP sequences tested.

How to read the evidence

Preliminary — biophysical study using model membranes; provides mechanistic insight but needs cellular validation.

When this study was published

Published in 2020; CPP membrane interaction mechanisms continue to be refined.

The bigger picture

This work refines our understanding of how CPPs interact with membranes, moving beyond simple curvature models to include membrane dynamics. This has implications for targeting CPP delivery to specific cell types with different membrane properties.

Questions still open

Do cell types with more fluid membranes show greater CPP uptake?
Can membrane fluidity be modulated pharmacologically to enhance CPP delivery?
How do membrane proteins affect the lipid mobility-CPP interaction?

Common questions

Why does vesicle size matter for drug delivery?

Vesicle size determines membrane curvature and lipid mobility. This study shows that lipid mobility — how freely membrane molecules can move — is more important than shape for allowing CPPs to cross. This knowledge helps design better drug delivery vehicles.

What is cytolysis in the context of CPPs?

Here, cytolysis refers to the process of CPPs directly passing through a membrane into the interior. It involves temporary, local changes in the membrane structure that allow the peptide to slip through without creating a permanent hole.

Read the original research

Effect of Vesicle Size on the Cytolysis of Cell-Penetrating Peptides (CPPs).

International journal of molecular sciences, 21(19)

View on PubMed ↗Publisher’s paper ↗

Citation

Sakamoto, Kazutami; Kitano, Takeshi; Kuwahara, Haruka; Tedani, Megumi; Aburai, Kenichi; Futaki, Shiroh; Abe, Masahiko; Sakai, Hideki; Ohtaka, Hiroyasu; Yamashita, Yuji. (2020). Effect of Vesicle Size on the Cytolysis of Cell-Penetrating Peptides (CPPs).. International journal of molecular sciences, 21(19). https://doi.org/10.3390/ijms21197405